Private Equity Deal-making Surges, with Gains in the Middle Market
After a quiet period set off by the coronavirus pandemic, private equity deal activity in the United States surged through mid-November. (authored by RSM US LLP)
M&A Due Diligence in the Era of Covid-19: PPP Loans Considerations
The Covid-19 pandemic has disrupted most economic sectors worldwide prompting governments to enact emergency stimulus measures to help businesses navigate the situation.
It’s Déjà Vu All Over Again for Physician Practice Acquisitions
What goes around comes around. In a trend mirroring that which occurred in the 1990s, physician practices are selling out to hospitals and private equity firms in increasing numbers.
Winning as a Seller: Prepare for Tax Impacts of Sale
Sellers are able to command top dollar if they go into the sales process ready to hit the ground running which includes tax preparation. (authored by RSM US LLP)
Keys to Addressing the EBITDA Impact of COVID-19
(authored by RSM US LLP) COVID-19 has significantly reduced M&A activity during the first and second quarters of 2020 and it is unclear when deal activity will get back to pre-pandemic rates.
Due Diligence Should Be More Than Numbers
Whether it is to gain access to new technologies or increase resources and market presence, more companies, large and small are considering a merger or acquisition.